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Background: Interleukin-7 is the master regulator of T-cell proliferation.
Results: IL-7 drives its receptor in amembranemicrodomain that regulates phosphorylation of associated tyrosine kinases JAK1
and JAK3, anchors IL-7 receptor to cytoskeleton and regulates STAT5 phosphorylation and nuclear translocation.
Conclusion:Membrane microdomains and cytoskeleton scaffold IL-7R-signalosomes and assist signaling protein transport.
Significance: Transient membrane and cytoskeleton organization shapes IL-7-signaling mechanisms in CD4 T-cells.
Interleukin (IL)-7 is the main homeostatic regulator of CD4
T-lymphocytes (helper) at both central and peripheral levels.
Upon activation by IL-7, several signaling pathways, mainly
JAK/STAT, PI3K/Akt and MAPK, induce the expression of
genes involved in T-cell differentiation, activation, and prolifer-
ation. We have analyzed the early events of CD4 T-cell activa-
tion by IL-7. We have shown that IL-7 in the first few min
induces the formation of cholesterol-enriched membrane
microdomains that compartmentalize its activated receptor and
initiate its anchoring to the cytoskeleton, supporting the forma-
tion of the signaling complex, the signalosome, on the IL-7
receptor cytoplasmic domains. Here we describe by stimulated
emission depletion microscopy the key roles played by mem-
branemicrodomains and cytoskeleton transient organization in
the IL-7-regulated JAK/STAT signaling pathway. We image
phospho-STAT5 and cytoskeleton components along IL-7 acti-
vation kinetics using appropriate inhibitors.We show that lipid
raft inhibitors delay and reduce IL-7-induced JAK1 and JAK3
phosphorylation.Drug-induceddisassembly of the cytoskeleton
inhibits phospho-STAT5 formation, transport, and transloca-
tion into the nucleus that controls the transcription of genes
involved in T-cell activation and proliferation. We fit together
the results of these quantitative analyses andpropose the follow-
ing mechanism. Activated IL-7 receptors embedded in mem-
brane microdomains induce actin-microfilament meshwork
formation, anchoring microtubules that grow radially from
rafted receptors to the nuclear membrane. STAT5 phosphory-
lated by signalosomes are loaded on kinesins and glide along the
microtubules across the cytoplasm to reach the nucleus 2 min
after IL-7 stimulation. Radial microtubules disappear 15 min
later, while transversal microtubules, independent of phospho-
STAT5 transport, begin to bud from the microtubule organiza-
tion center.
IL-7 is a crucial cytokine in the immune system (1, 2) in that
it induces the production of CD4 T-lymphocytes from precur-
sor cells in the thymus, regulates their proliferation, and con-
tributes to the homeostasis ofmature CD4T-cells in peripheral
blood. IL-7 is secreted by stromal cells in red marrow, thymus,
keratinocytes, dendritic cells, and endothelial cells (3). It binds
to a heterodimeric receptor, IL-7R,made up of two glycosylated
subunits: IL-7R (CD127, 65 kDa) (4), specific to IL-7 and thy-
mic stromal lymphopoietin (5), and the common  chain (c,
CD132, 56 kDa) shared by IL-2, 4, 7, 9, 15 and 21 receptors (2).
These two chains have common ancestors and share the same
topology; both chains are embedded in the membrane by a sin-
gle-pass transmembrane helix that connects the immunoglobin
fold structured ectodomain to the unstructured cytoplasmic
domain (6).
IL-7R is expressed at the surface of quiescent cells and grad-
ually disappears within 12 h of activation by IL-7 (7–9). Con-
versely, c is weakly expressed at the surface of quiescent CD4
T-cells, but activation by IL-7 rapidly up-regulates its expres-
sion, which peaks after 12 h and lasts for as long as 48 h. The
heterodimer is formed prior to IL-7 binding (10). IL-7 has high
affinity for the IL-7R heterodimer (Kd351012 M) and shifts
the equilibrium of receptor assembly. By contrast, IL-7 has low
affinity for its single proprietary chain, IL-7R (Kd3109 M)
and poor affinity forc (Kd250109 M) (11). The cytoplasmic
domain of IL-7R is long (195 residues), whereas that of c is
shorter (86 residues). Both domains are responsible for binding
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a large array of proteins involved in signaling pathways that
support cell survival and proliferation (2). These proteins
include Janus kinases, JAK1 and JAK3 (bound by IL-7R and
c, respectively), that are involved in the JAK/STAT pathway.
JAK1 and JAK3 recover their Tyr kinase activity when tethered
in close contact by the IL-7-activated receptor. They phosphory-
late themselves and then the IL-7R carboxyl-terminal Tyr
(Tyr(P)-456). This Tyr(P)-456 provides a single binding site for
STAT1, STAT3, and mainly STAT5a and STAT5b. Bound
STATs are then phosphorylated by the activated pJAK1pJAK35
complex (12). After phosphorylation, the STATs dissociate,
dimerize, and are translocated into thenucleus,where they induce
transcription of gene clusters involved in cell programs (12).
MAPKs and PI3K/Akt (signaling serine/threonine kinase) path-
ways are also triggeredby IL-7IL-7Rbinding andgive rise tomito-
genic and anti-apoptotic signals (1, 2). Although awealth of infor-
mation is available on the various kinases involved in IL-7 signal
transduction, less is known about the formation of the signaling
complex and its molecular mechanism.
We have previously shown that IL-7 binds to its preassoci-
ated receptor and then induces migration of the complex into
membrane microdomains, as observed by flotation ultracen-
trifugation through a sucrose gradient and by diffusion mea-
surements in living cells using fluorescence autocorrelated
spectroscopy (FCS) (10). These embedded complexes are then
confined by the cytoskeleton, as suggested by slowed receptor
diffusion measured by FCS, and are released by cytoskeleton
disassembly drugs (10). We used mass spectrometry (MS) to
analyze the content of the protein complex immunoprecipated
with IL-7R after IL-7-activation andCD4T-cell lysis in Triton
X-100 buffer (10). We found that activated IL-7R is associated
with many proteins known to be present in cytoskeleton and
membranemicrodomains andwith proteins involved in several
signaling pathways (10).
In the study reported here, we used superresolution optical
microscopy by stimulated emission depletion (13–15) to
observe structures smaller than the theoretical diffraction limit.
We showed for the first time how IL-7 in human primary CD4
T-lymphocytes induces the rapid formation of 1) membrane
microdomains, 2) dual actin-cortex organization, and 3) tran-
sient radial microtubules that bridge plasma and nuclear mem-
branes. We demonstrated that IL-7IL-7R compartmentaliza-
tion in membrane microdomains regulates JAK phosphorylation
and that confinement by the cytoskeleton upon IL-7 binding con-
trols STATphosphorylation, transport, and translocation into the
nucleus. We also herein provide a step-by-step description of the
IL-7-induced JAK/STAT signaling pathway that is central to CD4
T-cell activation and proliferation.
MATERIALS ANDMETHODS
Purification of Human CD4 T-lymphocytes—Venous blood
was obtained from healthy volunteers through the Etablisse-
ment Français du Sang (Centre Necker-Cabanel, Paris). CD4
T-cells were purified from peripheral bloodmononuclear cells,
checked for homogeneity and activation state, and cultured in
microplates, as described previously (10) and detailed in the
supplemental material. Cells were activated with 2 nM recom-
binant glycosylated human IL-7 (Cytheris) at 37 °C in a temper-
ature-controlled water bath and a 5% CO2 humidified
atmosphere.
Confocal and STED Microscopy—Images were acquired
above the diffraction limit on an inverted laser-scanning con-
focalmicroscope (LSM700, Zeiss) as detailed in the supplemen-
tal material. Images were acquired below the diffraction limit
on two DM16000CS/SP5 inverted laser-scanning confocal
microscopes using either continuous wave excitation STED
(CW-STED; Leica) (14) or pulsed excitation STED (STED;
Leica) (13).
Cell preparation and labeling of specific proteins is described
in detail in the supplemental material. Briefly, cells were puri-
fied, equilibrated in RPMI for 2 h at 37 °C, and then loaded on
polylysine-coated coverglasses for 20 min at 37 °C. When
needed, immobilized cells were treatedwith either cytochalasin
D (CytD; Sigma), colchicin (Col; Sigma), or cholesterol oxidase
(COase; Sigma) for 30min or sphingomyelinase (SMase; Sigma)
for 5 min at 37 °C and then activated with 2 nM IL-7. Cells were
fixed from 1 to 60 min after the addition of IL-7 with 1.5%
paraformaldehyde (PFA; Sigma) for 15 min at 37 °C and then
permeabilizedwhennecessary for 20min in ice-cold 90%meth-
anol/water solution when required for cytoplasmic labeling.
Cells were then rehydrated for 15 min in PBS plus 5% fetal
bovine serum (FBS) and then labeled. For pSTAT5 kinetics,
cells were pretreated with acidic buffer and washed twice in
PBS/FBS before fixation (10). GM1 gangliosides were labeled
with AlexaFluor-coupled cholera toxin subunit B (CtxB-Alexa-
Fluor488 or CtxB-AlexaFluor647; Invitrogen) on non-permea-
bilized cells that were either fixed with PFA or not. The other
proteins were targeted with corresponding primary antibodies.
The secondary antibodies used for pulsed STED microscopy
consisted of anti-mouse IgG-Chromeo494, anti-rabbit IgG-
Chromeo494, and anti-rabbit IgG-Atto647 (Active Motif).
Anti-mouse IgG-AlexaFluor488 (Invitrogen) and anti-rabbit IgG-
AlexaFluor488 (Invitrogen)wereused forCW-STEDandconfocal
microscopy. Anti-mouse IgG-AlexaFluor633 was used for confo-
cal microscopy. Cells were mounted in Vectashield/DAPI
medium (Vector Laboratories) for confocal microscopy and in
Mowiol (4-88; Sigma) supplemented with antifading Dabco (35
mg/ml; Sigma) for STEDmicroscopy.
Receptor Chain Diffusion Rate Analysis by Fluorescence
Cross-correlated Spectroscopy—All protein diffusions at the
surface of living human CD4 T-cells were acquired and ana-
lyzed in the absence and presence of raft and cytoskeleton
inhibitors by spot variation FCS (16) using an inverted laser-
scanning confocalmicroscope (LSM510, Zeiss), combinedwith
a ConfoCor2 FCS system (Zeiss), as described previously (10),
and detailed in the supplemental material.
Protein Assays by Flow Cytometry—Procedures are detailed
in the supplemental material. Briefly, CD4 T-cells were treated
with drugs, activated with IL-7, and then fixed with PFA. GM1
was assayed at the surface of non-permeabilized cells using
5 The abbreviations used are: pJAK, phosphorylated JAK; pSTAT, phosphory-
lated STAT; FCS, fluorescence autocorrelated spectroscopy; GM1, mono-
sialotetrahexosyl ganglioside; MTOC, microtubule organization center;
STED, stimulated emission depletion; CW-STED, continuous wave excita-
tion STED; CytD, cytochalasin D; Col, colchicin; COase, cholesterol oxidase;
sphingomyelinase; PFA, paraformaldehyde; CtxB, cholera toxin subunit B.
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CtxB-AF488. pSTAT5was assayed in permeabilized cells using
ice-cold 90%methanol/water, as described previously (10). The
kinetics of IL-7-induced actin and tubulin polymerization were
determined by cytometry. Activation in 96-well plates was
stopped by centrifugation (350  g) for 1 min at 4 °C. CD4
T-cells were labeled at the cell surface (anti-CD4-ECD) in 1%
FBS for 30 min at 4 °C. Cells were washed in cold PBS, centri-
fuged, and then permeabilized by 0.5% Triton X-100 for 10
min on ice. PFA was added (1.5% final), and the cells were cen-
trifuged for 5 min. They were then washed in cold PBS and
incubated for 30 min in PBS containing 5% FBS at 4 °C with
anti-actin-AF647 (sc1616, Santa Cruz Biotechnology, Inc.) and
anti-tubulin-AF488 (sc5286, Santa Cruz Biotechnology, Inc.).
Cells were washed in cold PBS and analyzed on a Cyan LXTM
cytometer (DakoCytomation) using FlowJo version 8.3.3 data
analysis software (Tree Star).
Western Blot Analysis—Immunoprecipitations were per-
formed from centrifuged lysates after treatment of purified
CD4 T-cells with Triton X-100 buffer using the indicated pri-
mary antibodies and immobilized protein G on Sepharose-4G
(GE Healthcare), and immunoprecipitated protein samples
were analyzed by Western blotting as described in the supple-
mental material.
RESULTS
STED Microscopy Analysis of IL-7-induced Membrane
Microdomains at the Surface of Human CD4 T-lymphocytes—
Human CD4 T-cells were isolated from the blood of several
healthy donors. Cells were re-equilibrated in culture
medium at 37 °C and 5% CO2 for 2 h and then activated by 2
nM IL-7 for 10 min. Membrane microdomains were labeled
through ganglioside (GM1) with cholera toxin B (CtxB)
tagged with AlexaFluor488. Z-stacks of images were
acquired by superresolution optical microscopy processing
CW-STED. Flattened three-dimensional reconstructions of
the half-cell tops are shown in Fig. 1, a–c, and corresponding
images at full resolution are shown in supplemental Fig. S1.
IL-7-activated CD4 T-lymphocytes showed several hundred
dense, circular spots. These spots were sparsely scattered over
the surface of quiescent cells. The number and size of these
GM1-enriched membrane microdomains were averaged over
100 CD4 T-cells (Fig. 1, d and e): 307 50 spots/cell of 90-nm
diameter in IL-7-activated cells, 12  6 spots/cell of 170-nm
diameter in quiescent cells. IL-7-induced spots were observed
over the entire surface of the cells. Spot distribution density was
sometimes asymmetrical, but no clustering was observed. The
formation of these microdomains started about 1 min after
adding IL-7. Half the spots were formed after 5 min, and the
maximum was reached after 15 min (Fig. 1f). The number of
spots then slowly decreased, whereas spot diameter increased
(Fig. 1g). No such spots were observed on IL-7-activated CD4
T-cells after 30 min of treatment with COase and 5 min of
treatment with SMase, as shown in Fig. 1c. These spots, or
membranemicrodomains, are large lipid rafts, enriched in cho-
lesterol, sphingomyelin, and GM1. GM1 distribution changed
upon IL-7 activation, but the overall number of GM1 at the
surface of T-cells was only slightly affected over the first 15min
of activation, as shown by flow cytometry analysis of GM1
labeled with CtxB-AF488 (supplemental Fig. S2).
Membrane Domain Disassembly Inhibits JAK Phosphorylation—
Inorder to investigate the roleplayedbymembrane compartmental-
ization in the IL-7-induced phosphorylation of JAKs and STATs, we
analyzed the kinetics of IL-7-induced JAK1, JAK3, andSTAT5phos-
phorylation before and after treatment with optimal concentrations
of lipid raft inhibitors (COase and SMase). Cytoplasmic concentra-
tions of pJAK1 (Tyr(P)-1034/Tyr(P)-1035), pJAK3 (Tyr(P)-980/
Tyr(P)-981), andpSTAT5 (Tyr(P)-694)were comparedby averaging
densitometric analysesofECLbands fromfiveWesternblots (Fig. 2).
Intheabsenceofanyinhibitors,pJAK1andpJAK3startedtoaccumu-
late1minafterIL-7activation,reached50%ofthemaximumconcen-
trationafter5min,peakedafter15min,anddecreasedthereafter (Fig.
2, a, c, and d). In the presence of COase and SMase, JAK1 and JAK3
were phosphorylated 10 timesmore slowly after the addition of IL-7,
peaked 60 min later at only 25% of the optimal concentration
observed in the absence of raft inhibitors, and then decreased after-
FIGURE 1. Membrane microdomain formation induced by IL-7 at the
CD4 T-cell surface, resolved by STED microscopy. The binding of CtxB-
AF488 on the GM1-enriched region was imaged by CW-STED microscopy
after 5 min of activation by IL-7 (b) at the surface of nonstimulated (NS) lym-
phocytes (a) or COase- and SMase-treated cells (c). Sliced images of the half-
cell top at the opposite side of the coverglass were flattened. Image colors
were inverted and converted to grayscale. Original images are shown in sup-
plemental Fig. S1. Total GM1 binding per cell was assayed by cytometry and
plotted in supplemental Fig. S2. The number of GM1-enriched membrane
microdomainswas averaged from100CD4 T-cells (d) from slides shown in a
andb. The sizeofmembranemicrodomainswas averaged from100 cells from
the same slides; the measurement of CtxB-AF488 fluorescence intensity in
one membrane microdomain is shown for nonstimulated (dashed line) and
IL-7-stimulated cells (continuous line) (e). Membranemicrodomain number (f)
and size (g) are plotted versus time after IL-7 activation. Error bars, S.E.
Microdomains and Cytoskeleton Regulate IL-7 Response
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ward (Fig. 2,b, c, andd). Lipid raft inhibitors affected both JAKphos-
phorylation efficiency and kinetics. In untreated cells, pSTAT5
reached50%oftheplateauconcentrationinthecytoplasm7minafter
activation and reached theplateau concentration after 15min (Fig. 2,
a and e). In the presence of raft inhibitors, only 17% of the pSTAT5
plateauwas reached (Fig. 2,b and e).Aquantitative analysis of overall
intracellularpSTAT5concentrationsbyflowcytometrycorroborated
the effects of the combined inhibitors and their kinetics and showed
thatCOase has a greater inhibitory effect than SMase (Fig. 2f).
IL-7 Induces Transient Cytoskeleton Structuring—Investiga-
tions by pulsed STED microscopy showed that IL-7 induces a
two-step structural organization of cytoskeleton in CD4T-cells
(Fig. 3). Early structuring occurred 1 min after IL-7 was added.
We noted, in quiescent cells, that actin was mainly concen-
trated in the vicinity of the plasma membrane and was diffuse
elsewhere in the cytoplasm (Fig. 3, a and d). Tubulin was dif-
fused throughout the cytoplasm (Fig. 3, a and f). After IL-7
activation, actin formed two dense layers: the first beneath the
plasma membrane and the second surrounding the nuclear
membrane (Fig. 3, b and e). Strikingly, tubulin was seen to form
rods organized radially through the cytoplasm (250–1000 nm
in length) and bridging plasma and nuclear membranes (Fig. 3,
b and g). These rods showed labeling patterns consistent with
microtubules, the two ends of which were deeply anchored in
both actin cortexes. Actin layers appear denser at the junction
point with tubulin rod patterns. We counted 5–25 tubulin rod
patterns per 500-nm thickness of cell slice image (23 threads in
Fig. 3b, six of which are shown in the enlarged boxed area in Fig.
3g). No such threads were observed in non-activated control
cells (Fig. 3f). These radial microtubules disappeared 15 min
after the addition of IL-7 and had an individual life span of
about 5–10 min. In the largest space in the cytoplasm, nascent
microtubules budded from the microtubule organization cen-
ter (MTOC) 10 min after the addition of IL-7. Whereas the
radial microtubules disappeared, transversal microtubules
grew from theMTOC in a star pattern (Fig. 3c) to surround the
nucleus after 45min, as detailed by pulsed STEDmicroscopy in
Fig. 3h and supplemental Fig. S3 (full resolution). Fig. 3h shows
nine microtubule bundles radiating from the MTOC and the
separation of each into single fibers. The boxed region in Fig. 3h
is enlarged in Fig. 3j, which shows microtubule details. These
long transversal microtubules in Fig. 3j were comparable in
section diameter and staining irregularity with the short radial
microtubules shown in Fig. 3g. These structureswere very fuzzy
in conventional microscopy (Fig. 3, i and k). Logically, IL-7
failed to induce any cytoskeleton structural organization 30
min after the cells had been treated with drugs that inhibit
microfilament assembly (CytD) or microtubule assembly (Col)
and showed fuzzy actin and tubulin distribution as seen in non-
stimulated cells.
The kinetics of IL-7-induced actin and tubulin polymeriza-
tion were determined by cytometry. Cells were permeabilized
with Triton X-100 and then fixed with PFA. Actin and tubulin
were labeled with anti-actin-AF647 and anti-tubulin-AF488
(Fig. 3l). IL-7 increased the levels of actin and tubulin detected
in the first 10 min; actin polymerization in microfilaments and
tubulin assembly in microtubules were seen to stabilize these
structures in the Triton-permeabilized cells. The decrease in
tubulin after 15minmay be interpreted as due to disassembly of
the IL-7-induced radial microtubules preceding the formation
of transversal microtubules from the MTOC. Investigations
after treatment with CytD and then IL-7 activation (5 min)
confirmed that microtubule formation is dependent on micro-
filament organization (Fig. 3m). Observations by STEDmicros-
copy of cells treated with Col confirmed that microfilament
organization beneath the plasma membrane is independent of
microtubule formation, but the perinuclear actin cortex
depends on the presence of microtubules.
Actin Cortex Anchors Activated IL-7 Receptors—We have
previously measured by FCS the diffusion rate Deff of IL-7R
(0.21m2/s) and shown by fluorescence cross-correlated spec-
FIGURE 2. Disassembly of membrane microdomains inhibits JAK1 and
JAK3 phosphorylation kinetics. JAK1, JAK3, and STAT5 phosphorylation
wasmeasured byWestern blotting during IL-7 activation of CD4 T-cells in the
absence (a) or in the presence (b) of raft inhibitors (1 unit/ml, i.e., 31MCOase
and 0.1 unit/ml, i.e., 2.7 M SMase). The kinetics of pJAK1 (c), pJAK3 (d), and
pSTAT5 (e) accumulation in the presence or absence of combined lipid raft
inhibitorswere plotted frombanddensity (sumof pixel intensities in a rectan-
gle boxing the band divided by the corresponding band of the unphospho-
rylated species and corrected for the offset at time 0). Maximum density was
set to 100%, and minimum density was set to 0 for a treated/untreated blot
pair. Percentage values were averaged from five blot pairs (five independent
CD4 T-cell donors). Error bars, S.E. The results of intracellular pSTAT5 assays by
FACS were plotted against inhibitor concentration 15 min after IL-7 activa-
tion, without and with lipid raft inhibitors, separately (COase, SMase) or in
unit/unit combination (COase SMase) (f).
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troscopy that the addition of IL-7 slows the diffusion of its pre-
assembled receptor IL-7Rc from 0.17 down to 0.02 m2/s
(10).We have also demonstrated that receptor slowing is a con-
sequence of its IL-7-induced recruitment by the cytoskeleton.
We detail here the respective roles of microfilaments and
microtubules. The diffusion rate and confinement time of the
labeled complex were measured by spot variation FCS (16, 17)
in live CD4 T-cells. Diffusion rate is inversely proportional to
the slope of the diffusion time versus spot area (02) plot. Con-
finement time 0 was extrapolated in the same plot as the y
intercept. Diffusion plots of the IL-7RmAb-AF488IL-
7biotinSAF633 complex are given herein (Fig. 4a), along with
bar graphs comparing diffusion rates and confinement times
(Fig. 4b) for increasing doses of CytD. Details of thesemeasure-
ments are given in supplemental Fig. S4. The dose-response
obtained with CytD illustrates receptor release for diffusion
when actin filaments are depolymerized. The diffusion rate of
activated receptors was maximal from 20 MCytD (Deff 0.23
m2/s) (Fig. 4b). Microtubule depolymerization by Col did not
release any activated receptors, and Col did not increase the
effect of CytD on receptor diffusion (Fig. 4b). Lipid raft inhibi-
tors (COase, SMase, or COase SMase) failed to release recep-
tors confined in actin-scaffold structures (Fig. 4b), but in the
presence of CytD, treatment with COase SMase did increase
the diffusion rate of cytokine-bound receptors (Deff  0.35
m2/s); they diffused even more rapidly than cytokine-free
receptor (Deff  0.17 m2/s) and IL-7R single chain (Deff 
0.21 m2/s) on untreated cells, and confinement time was zero
(i.e. characteristic of free two-dimensional diffusion out of
membrane microdomains). The activated receptors diffused
freely as the cytoskeleton meshing the membrane inlet vicinity
was disassembled. We noted that although actin microfila-
ments anchored IL-7-activated receptors even in the absence of
microtubules and membrane microdomains, the anchoring
kinetics under these conditions were altered.
Cytoskeleton Disassembly Inhibits STAT Phosphorylation—
The involvementof IL-7-inducedcytoskeletonorganization in the
JAK/STATpathwaywas assessed by comparing the effect of cyto-
skeleton inhibitors on the IL-7-induced phosphorylation of JAK1,
JAK3, and STAT5 (Fig. 5). We determined the kinetics of pJAK1
(Tyr(P)-1034/Tyr(P)-1035), pJAK3 (Tyr(P)-980/Tyr(P)-981), and
pSTAT5 (Tyr(P)-694) accumulation in the cytoplasm byWestern
blotting after treatment with CytD (20 M) and Col (10 M) (Fig.
5b) and compared the results with pJAK and pSTAT5 concentra-
tions in the absenceof these cytoskeleton inhibitors (Fig. 5a). Band
densities were averaged from five Western blot pairs processed
from the cells of five healthy blood donors. Cytoskeleton assembly
inhibitors had only weak effects on the kinetics of JAK1 and JAK3
phosphorylation (Fig. 5, c and d). Conversely, STAT5 phosphory-
lation was substantially delayed and reduced (Fig. 5e). When
T-cells were pretreated with CytD and Col, STAT5 phosphoryla-
tionwaseight times slower andpeaked45minafter theadditionof
FIGURE 3. IL-7 induces cytoskeleton structuring observed by STED
microscopy.Microfilament andmicrotubule organization was compared by
pulsed-STEDmicroscopy before (a), 5 min (b), and 45min (c) after IL-7 activa-
tion of human primary CD4 T-cells. Tubulin from microtubules was labeled
withmouse anti-tubulin and anti-mouse-chromeo494 (green), and actin from
microfilaments was labeled with rabbit anti-actin and anti-rabbit Atto647
(red). Details of actin organization are shown in d and e, and details of tubulin
organization are shown in f and g from the boxed area in nonstimulated and
IL-7-activated cell images (a and b, respectively). Image colors were inverted
and converted into grayscale. Original full resolution images are shown in
supplemental Fig. S3). Radial microtubules passing through the cytoplasm 5
min after IL-7 activation are indicated by arrows and contrast with the cyto-
plasm of unactivated cells. Images show tubulin organization in cells 45 min
after activation, by STED (h) and regular confocal microscopy (i) with the
boxed area enlarged in corresponding panels (j and k). Kinetics of IL-7-induced
actin and tubulin polymerization, by cytometry, are plotted in l with mean
fluorescence intensity (MFI) versus time (min) with bars indicating S.E. from
five independent experiments (five donors). Cells were permeabilized by
0.5%Triton X-100 and then fixed by 1.5%PFA. Actin and tubulinwere labeled
with anti-actin-AF647 and anti-tubulin-AF488. Mean fluorescence intensity
assays by cytometry were then performed with the same labeling after Col
and CytD treatments (30 min) and then IL-7 activation for 5 min (m).
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IL-7atonly28%of theoptimalpSTAT5concentrationobserved in
the absence of drugs and thendecreased afterward (Fig. 5e). These
observations were confirmed in intracellular pSTAT5 assays by
flow cytometry summing cytoplasmic and nuclear concentrations
(Fig. 5f). Col, CytD, andColCytDwere seen to cause a dose-de-
pendent alteration in pSTAT5 concentrations measured by flow
cytometry, which fell to aminimum fromCol1M and showed
a slow slope drift with CytD 2 M (Fig. 5g). CytD had a more
marked effect than Col on pSTAT5 plateau concentrations. Col
accentuated the inhibitory effect of CytD when used in
combination.
Cytoskeleton Disassembly Alters STAT Transport Kinetics
and Translocation—Because IL-7 was observed to induce rapid
and marked cytoskeleton reorganization, we investigated the
effects of CytD and Col on pSTAT5 transport across the cyto-
FIGURE 4. Actin microfilament meshwork anchors activated IL-7 recep-
tors, and receptor embedding in membrane microdomains is indepen-
dent of this anchoring. Two-dimensional diffusion of IL-7R labeled by
AF488-coupled monoclonal antibody anti-IL-7R was measured at the sur-
face of living CD4 T-cells by FCS and fluorescence cross-correlated spectros-
copy. Diffusion times D (in 10
3 s) in the presence of IL-7biotinSAF633 are
plotted versus the surface area2 intercepted by the confocal volume (in 103
nm2): autocorrelation function (ACF) of IL-7RmAb-AF488 in the absence of
IL-7 (E; NS) and crosscorrelation function (CCF) of IL-7RmAb-AF488 with
IL-7biotinSA633 without CytD (●) in the presence of increasing concentra-
tions of CytD (). Diffusion plots (fluorescent particle diffusion time versus
surface area intercepted by the variable confocal volume) are shown in a. All
cross-correlation curves are detailed in supplemental Fig. S4. Slopes of the
linear regression give effective diffusion rates Deff, and y intercepts extrapo-
late confinement time 0, as described previously (16, 17). b, Deff (top) and 0
(bottom) are shown in the bar graph for IL-7RAb-AF488 in the absence of IL-7
(NS), in thepresenceof IL-7biotinSA633without inhibitor (0), and thenwith
different pretreatments using the following inhibitors: CytD (from 1 to 100
M), Col (10 M), CytD (20 M)  Col (10 M), COase (1 unit/ml, i.e., 31 M),
SMase (0.1 unit/ml, i.e., 2.7 M), and COase  SMase. All, COase  SMase 
CytD Col. Error bars, S.E. from five independent experiments.
FIGURE 5. Cytoskeleton disassembly inhibits STAT5 phosphorylation.
JAK1 and STAT5 phosphorylation kinetics were analyzed byWestern blotting
during IL-7 activation of CD4 T-cells in the absence (a) or in the presence of
cytoskeleton inhibitors (20MCytD and10MCol) (b).Maximumdensitywas
set to 100% and minimum to 0 for a treated/untreated blot pair. Percentage
values were averaged from five blot pairs (five independent CD4 T-cell
donors) (c and d). Bars, S.E. Band densities were computed from the sum of
pixel intensities in a rectangle boxing the band divided by the corresponding
band of the unphosphorylated species and corrected for the offset at time 0.
Mean fluorescence intensity (MFI) of intracellular pSTAT5 staining measured
by FACS were also averaged from five independent CD4 T-cell donors and
was plotted versus time (e). The dose-dependent inhibition of the phosphoryl-
ation response to IL-7 activationwasmeasured by FACS (f).
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plasm and translocation into the nucleus because this signaling
intermediate is phosphorylated below the plasma membrane
and is known to promote the transcription of many nuclear
genes in synergy with other factors. We used pulsed STED
microscopy to compare pSTAT5 distribution kinetics in IL-7-
induced CD4 T-cells in the absence or in the presence of cyto-
skeleton inhibitors before activation (Fig. 6). In the absence of
inhibitors, pSTAT5 appeared in the cytoplasm, below the
plasma membrane, 1 min after the addition of IL-7 (Fig. 6a),
peaked from 5 to 10 min, decreased afterward (Fig. 6d), and
disappeared after 45min (Fig. 6e). pSTAT5was observed in the
nucleus from the second minute. It accumulated there (Fig. 6,
b–e), reached 50% of its maximum after 5–10 min, reached the
maximum after 15–30 min, and decreased thereafter (Fig. 6g).
STEDmicroscopy showed that some pSTAT5 colocalized with
microtubules; these pSTAT5 appeared as threads across the
cytoplasm, as shown 5 min after the addition of IL-7 in the
enlarged image in Fig. 6c.
Pretreating cells for 30 min with CytD  Col significantly
altered the quantity of pSTAT5 in the cell, and 45 min after the
IL-7 was added, most of the pSTAT5 was found in the inflated
cytoplasm (Fig. 6f) instead of in the nucleus, as observed in the
absence of inhibitors (Fig. 6e). Given that microtubules are
clearly involved in the transport and translocation of pSTAT5
into the nucleus, we investigated the interaction between
pSTAT5 and tubulin and two of the major molecular motor
families that glide along microtubules: kinesins and dyneins
(18). To do this, we activated CD4T-cells with IL-7 (2 nM) for 1,
2, 3, 5, 10, 20, and 45min and then harvested, washed, and lysed
the cells in 0.5%Triton buffer.We immunoprecipitated protein
complexes from centrifugation supernatants with anti-tubulin
, anti-UKHC (targeting the universal heavy chain common to
all kinesin complexes), or anti-dynein intermediate chain and
viewed Western blots after treatment with anti-pSTAT5 (Fig.
6i) or STAT5 (Fig. 6j). When the cytoplasmic membrane was
lysed using ice-cold 0.5% Triton, pSTAT5was immunoprecipi-
tated with tubulin and UKHC in the first 5 min after IL-7 acti-
vation but was not detectable thereafter. When both the cyto-
plasmic and nuclear membranes were thoroughly lysed using
1% Triton buffer and cell freezing and thawing cycles, pSTAT5
and STAT5 were detectable for up to 20 and 45 min, respec-
tively, after IL-7 activation when immunoprecipitated with
tubulin (Fig. 6k). This observation suggests that the microtu-
buleswere carried awaywith the cell lysate centrifugation pellet
under mild lysis conditions when microtubules anchor to the
nucleus more than 2 min after IL-7 activation. Microtubules
were released from nuclear membrane anchorage under stron-
ger lysis conditions. This further suggests that microtubules
grow from the membrane through the nucleus. The time shift
observed in Fig. 6k between the pSTAT5 and STAT5 amounts
immunoprecipitated with tubulin suggests that both phosphory-
lated and unphosphorylated STAT5 are carried along microtu-
bules. Despite the presence of dynein in the cytoplasm (Fig. 6j,
lane C), no STAT5 was coimmunoprecipitated with the dynein
intermediate chain. These results seem to disqualify dynein
fromany involvement in pSTAT5 and STAT5 transport inCD4
T-cells and spotlight kinesins as molecular motor candidates
for both the anterograde and retrograde transport of pSTAT5
and STAT5, respectively.
DISCUSSION
IL-7 induces a variety of responses in CD4 T-lymphocytes,
primarily through the main common c-signaling pathways
JAK/STAT, Akt/PI3K, and MAPK (2). These pathways have
been described as reaction cascades and are processed within
FIGURE 6. Kinetics of kinesin-assisted pSTAT5 transport and transloca-
tion into the nucleus observed by STEDmicroscopy after IL-7 activation.
pSTAT5 was labeled with a specific primary mAb and then a secondary anti-
rabbit antibody, Atto647, on PFA-fixed cells 1, 3, 5, 15, and 45 min after the
addition of IL-7 and imaged on a pulsed STED microscope (a–e). Details of
pSTAT threads are boxed from the 5 min image (c). f, image obtained 45 min
after the addition of IL-7 in a cell pretreated with CytD Col. Pixel intensity
sum for the nucleus and cytoplasm areas (ROI, region of interest) was aver-
aged for five cells andplotted against IL-7 activation time in the absence (g) or
in the presence of cytoskeleton inhibitors (h). pSTAT5 (90 kDa) was analyzed
byWestern blotting after immunoprecipitationwith anti-tubulin, anti-UKHC,
and anti-dynein from 1 to 20 min after IL-7 activation (i). Tubulin (54 kDa),
UKHC (120 kDa), and dynein (75 kDa) immunoprecipitations (IP) with anti-
STAT5 were analyzed against activation time (j); lane C shows the unprecipi-
tated lysate control. pSTAT5 and STAT5 are labeled from proteins immuno-
precipitated by anti-tubulin from cells thoroughly lysed by 1% Triton X-100
buffer and then frozen and thawed twice and assayed from 1 to 45min in the
absenceor presenceof cytoskeleton inhibitors separately (CytD andCol) or in
unit/unit combination (CytD Col) (k). Error bars, S.E.
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the signaling complex, the signalosome, which is associated
with the cytoplasmic domains of the IL-7 receptor rather than
being free in the cytoplasm. This clustering of protein kinases
with signaling intermediates optimizes substrate diffusion and
presentation from one enzyme to another and organizes gradi-
ents of signaling intermediates (19). Themolecular assembly of
the reaction complexes that form the IL-7R signaling complex,
or signalosome, needs to be further documented. Consistent
with this, we have previously shown, by time-resolved micro-
imaging and single molecule analyses, that IL-7 binds to its
preassembled dimeric receptor then induces its compartmen-
talization in membrane microdomains and its interaction with
the cytoskeleton meshwork (10). We have also demonstrated,
by a proteomics approach, that IL-7R activation initiates the
formation of signaling complexes involving signaling pathway
proteins but also many components of the cytoskeleton and a
number of proteins associated with membrane microdomains
(10).
In the present study, we demonstrate, in human primary
CD4 T-lymphocytes, that microdomains and cytoskeleton play
important functional roles in structuring the IL-7R signaling
complex and in regulating its signal transduction kinetics and
intensity along the JAK/STAT pathway. Fig. 7, a–f, gives an
outline of our observations in the form of a time-sequence rep-
resentation of the membrane microdomain formation and
cytoskeleton structuring induced by IL-7. In Fig. 7, g–j, we
FIGURE 7. Schematic of the IL-7-induced cytoskeleton organization and JAK/STAT signal transduction mechanism. a–f sketch the formation of mem-
branemicrodomains andmicrotubules from1 to45minafter IL-7 activationofCD4T-cells.Black circles, plasmaandnuclearmembranesof a singleCD4T-cell;
top boxes, percentages of cytoplasmic (green) and nuclear (red) pSTAT5; bracketed indications (top), correspondence with figures cited under “Results.”
g, IL-7-free IL-7Rc heterodimers are embedded in the lipid bilayer, outside microdomains in quiescent cells. JAK1 and JAK3 are constitutively bound to
IL-7R and IL-7Rc, respectively. h, binding of IL-7 brings the transmembrane domains closer together. i, formation of the microdomains that hold the
transmembrane domain straight and pull the cytoplasmic domains closer together. Phosphorylations are indicated by red spheres (j). The FERM proteins,
moesin or ezrin (F), connect the submembrane FERM binding domain of IL-7R to F-actin. Integrin chains are linked to F-actin through praxillin (P) or talin (T)
complexed to vinculin (V). ABP, actin-binding proteins; S, proteins inhibiting F-actin elongation; R, proteins involved in filament ramification. Microtubules are
anchored to actinmicrofilament through the putative FERMprotein candidate (F) and FERMbinding protein (X) capping themicrotubuleminus-end. STAT5 is
carried in retrograde kinesin cargo alongmicrotubules toward the membrane (minus-end direction). STAT5 binds on IL-7R Tyr(P)-456 and then is phospho-
rylated by pJAK1pJAK3. pSTAT5 is carried in the anterograde kinesin cargo as a dimer toward the nucleus (plus-end direction) and translocates through the
nuclear pore (NPC) by means of the importin/Ran-GDP system. Minimum times for each mechanism step are indicated by red arrows.
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interpret, in light of our results, the molecular mechanism of
IL-7R-mediated JAK/STAT signal transduction, from IL-7
binding at the surface of CD4 T-cells to pSTAT5 transport into
their nucleus.
We have previously shown that IL-7Rc complexes assem-
ble spontaneously by means of their ectodomains (11), as also
demonstrated for homologous IL-2Rc complexes (20–22).
IL-7Rc diffuses rapidly in two dimensions at the surface of
quiescent CD4 T-cells (10) (Fig. 7g). Very few membrane
microdomains, labeled with CtxB targeting their GM1, were
observed at the surface of these unactivated cells. Actin is
mostly concentrated beneath the plasmamembrane, and tubu-
lin is very diffuse throughout the cytoplasm, not forming any
highly structured patterns (Figs. 3 (a, d, and f) and 7a). When
IL-7 is added and binds to its receptor, the IL-7Rc ectodo-
mains change shape, pull the long transmembrane domains
closer together, and then bring their endodomains into close
proximity, as proposed by Walsh and colleagues (6, 23) and
summarized in Fig. 7, g–i. This mechanism has also been pro-
posed for the IL-2Rc homologous system (22, 24).We found
that a few min after IL-7 was added, about 300 membrane
microdomains were formed over the entire surface of the T-cell
(Figs. 1b and 6a). These were 90 nm in diameter (i.e. 50% larger
than the practical resolution of our STEDmicroscope).No such
microdomains were observed after rapid treatment with cho-
lesterol oxidase and sphingomyelinase, suggesting the enrich-
ment in cholesterol and sphingomyelin in these structures. The
fact that no suchmicrodomains were present prior to the addi-
tion of IL-7 proves that they were not induced by the pentam-
eric cholera toxin B used to label them. When IL-7 binding
pulled IL-7R and c endodomains together, JAK1 and JAK3
were tethered in close contact, and the JAK1JAK3 complex
recovered its tyrosine kinase activity and phosphorylated JAK1
(Tyr(P)-1034/Tyr(P)-1035) and JAK3 (Tyr(P)-980/Tyr(P)-981)
themselves and IL-7R carboxyl-terminal Tyr (Tyr(P)-456)
(Fig. 7i). Raft inhibitors delayed and reduced the phosphoryla-
tion of JAK1, JAK3, and STATs without abrogating it com-
pletely. Microdomain thickness and viscosity might regulate
JAK1 and JAK3 phosphorylation through tilt control of the sin-
gle transmembrane helical domain of the two chains, tethering
their cytoplasmic domain and cognate kinase in close contact
(10). Because STATs are phosphorylated by activated JAKs,
inhibition of STAT phosphorylation should be a consequence
of JAK inhibition.
It has been suggested that the IL-7R cytoplasmic sequence
contains a FERM domain binding motif following the trans-
membrane domain (10). Another shorter FERM binding site
might be questioned in the sequence of the c cytoplasmic
domain. Given that FERMproteinsmoesin and ezrin have been
immunoprecipitated with activated IL-7-receptor complex
(10), they might anchor rafted IL-7-activated receptor to F-ac-
tin and initiate the microfilament organization that structures
the actin cortex lining the plasmamembrane (25). This anchor-
ing prevents IL-7R diffusion and stabilizes the recruitment of
other receptors, such as integrin (10, 26). Tubulin anchors to
actin microfilaments, potentially through ezrin at its minus-
end (27), and polymerizes to form a microtubule that grows by
its plus-end (28, 29), crosses the cytoplasm, and reaches the
nucleus less than 2 min after the addition of IL-7 (Figs. 3g and
7c). Actin molecules assemble along the nucleus envelope to
formmicrofilaments that form a tight cortex anchoring micro-
tubule plus-ends. We found kinesin heavy chains, but not
dynein, among the proteins coimmunoprecipitated with
STAT5 from IL-7-activated cells. We also found STAT5 and
pSTAT5 coimmunoprecipitated with kinesin heavy chains
from IL-7-activated T-cells. This suggests that these microtu-
bules may drive STAT5 with retrograde kinesin cargo toward
the rafted IL-7R. STAT5 then binds toTyr(P)-456 at the IL-7R
carboxyl terminus and is phosphorylated on its Tyr-694 by
pJAK1pJAK3 (Fig. 7j). pSTAT5 dissociates from the receptors,
dimerizes through Tyr(P)-694/Src homology 2 domain inter-
molecular association, and is driven by anterograde kinesins
toward the nuclear pore. A nuclear localization signal has been
found in STAT5 sequences (30); pSTAT5 might be imported
through the nucleopore by the -importin system (31).
pSTAT5 dimers contribute, along with other factors, to the
transcription of several genes, such as that coding for IL-2R.
Unbound pSTAT5 dimers are then dephosphorylated. A
nuclear export signal was also identified in the STAT5
sequences (32). STAT5 might be translocated out of the
nucleus by the exportin system. It is then uploaded by retro-
grade kinesin and driven up to rafted receptors. In our studies,
pSTAT5 translocation into the nucleus was fastest 5 min after
the addition of IL-7 (Figs. 6g and 7d). It accumulated in the
nucleus until the radial microtubules began to depolymerize
10–15 min after the addition of IL-7 and then gradually disap-
peared from the cytoplasm (15–30 min). Tubulin was then
recruited by transversally growing microtubules from the
MTOC 10 min after the addition of IL-7 (Figs. 3 (c and h) and
7e); our observations by pulsed STEDmicroscopy did not show
any colocalization of pSTAT5 with transversal microtubules
from the MTOC system organized in a star pattern around the
nucleus. Cellular pSTAT5, as assayed by cytometry, peaked 15
min after the addition of IL-7, corresponding to the total
amount in the cytoplasm and nucleus.Microscopy showed that
nuclear concentrations peaked 30 min after the addition of
IL-7, whereas cytoplasmic pSTAT5 decreased from 10 min
after the IL-7 addition (Fig. 6g).
Membrane microdomains have also been implicated in the
T-cell receptor signaling cascade, where they are recruited
transiently following receptor engagement to initiate the
assembly of signaling machinery (33). Protein association with
membrane microdomains is likely to be facilitated by raft coa-
lescence following T-cell receptor triggering, a process pro-
moted by cortical actin reorganization and enhanced by the
engagement of costimulatory receptors, such as CD28, clus-
tered at the immunological synapse (34). No such clustering is
observed during the formation of IL-7R signaling complexes
that are dispatched throughout the cell. Induction of cytoskel-
eton structuring has been described with many cytokines and
chemokines but mostly over longer time spans. Pioneering
studies on prolactin receptor (35), growth hormone receptor
(36), and epidermal growth factor receptor (37) have suggested
that machineries carried by the cytoskeleton might be involved
in STAT5 and pSTAT5 distribution and proposed that rapid
organization was involved. Here, in our study, we used super-
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resolution optical microscopy to describe in detail how radial
microtubules are formed within a few min of IL-7 activation,
bridging plasma and nuclear membranes across the narrow
cytoplasmofCD4T-lymphocytes. This is the first time that this
transient organization of radial microtubules, resembling the
spokes of a wheel in an equatorial slice of the T-cell, has been
described (Fig. 7d). We counted about one microtubule per
membrane microdomain embedding IL-7R signaling complex.
These microtubules bud from the actin cortex 1 min after the
addition of IL-7 and then reach the nucleus in less than 1 min.
They have a life span of 5–15 min. Kinesin-assisted transport
along 1-m-long microtubules has been described in the sec-
ond range, but what role do these radial microtubules play in a
cytoplasm that is so narrow that pSTAT5 should be able to
cross it by passive diffusion in less than 1 s? When we added
cytoskeleton inhibitors, the nuclear translocation of pSTAT5
was very slow, and it accumulated in the cytoplasm. In
untreated IL-7-activated cells, pSTAT5 was found not only
along microtubules, but microtubules might facilitate “fast
track” nuclear import through amicrotubule-importin interac-
tion (38); the nuclear translocation of pSTAT5 might be the
bottleneck in the JAK/STAT signal transduction induced by
IL-7 and may require active molecular motor assistance for
guidance and ushering, not for speed.
Inmore general terms, our functional approach has led to the
discovery of IL-7 signal transduction mechanisms involving
membrane microdomains and transient cytoskeleton structur-
ing that regulate the kinetics and amplification of the JAK/
STAT pathway that is central to CD4 T-cell responses. Mem-
brane microdomains optimize the receptor response, and
microtubules and molecular motors shorten signal transduc-
tion time from membrane to nucleus pore and secure the
nuclear translocation of transcription factors, rapidly priming
the cell response. This is consistentwith the sensing role ofCD4
T-cells that is so central to the immune survey and response.
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SUPPORTING INFORMATION 
Inventory of supporting information 
 1- Supplemental experimental procedure 
 2- Supplemental references 
 3- Supplemental figures 
  Figure S1 is related to Figure 1 
  Figure S2 is related to Figure 1 
  Figure S3 is related to Figure 3 
  Figure S4 is related to Figure 4 
 
1- SUPPLEMENTAL EXPERIMENTAL PROCEDURE 
Human CD4 T-lymphocyte purification.  
Venous blood was obtained from healthy volunteers through the EFS (Etablissement Français 
du Sang, Centre Necker-Cabanel, Paris). PBMC were purified by density gradient 
centrifugation on Lymphoprep solution (Axis-Schield). CD3+/CD4+ cells were prepared from 
human PBMC by separation on magnetic beads (CD4+ negative purification kit, Miltenyi 
Biotec) as described previously (Rose et al., 2010). The enriched CD4 T-cell population 
contained >95% CD3+/CD4+ cells was controlled by flow cytometry on a Cyan LX™ 
cytometer (DakoCytomation). Data were acquired with Summit v4.1 software (Dako) and 
analyzed using FlowJo v8.3.3 software (Tree Star). The quiescence of recovered CD4 T-cells 
were controlled by the absence of IL-2R (CD25) and the presence of IL-7R (CD127) at the 
cell surface. Labelling procedures were detailed previously (Rose et al., 2010). 
CD4 T-cells were resuspended at 106cells/ml in RPMI 1640 medium (Lonza, Verviers, 
Belgium) supplemented with 5% foetal bovine serum (FBS), 50 mM HEPES pH 7.4, 
glutamine, penicillin, streptomycin and fungizone (complete medium) and equilibrated at 
2 
least 2 h at 37°C in a 5% CO2 humidified atmosphere.  
 
Confocal microscopy.  
Images were acquired above the diffraction limit on an inverted laser scanning confocal 
microscope (LSM700, Zeiss), with a water-immersion apochromatic 40x/1.2 NA objective 
lens (Zeiss) for unfixed cells or an oil-immersion plan-apochromatic 63x/1.4 NA objective 
lens (Zeiss) for PFA-fixed cells. Images were acquired and analyzed with the ZEN software 
(Zeiss).  
 
Super-resolution STED microscopy. Images were acquired below the diffraction limit on 
two inverted laser scanning confocal microscopes DM16000CS/SP5 using either continuous 
wave excitation STED (TCS STED-CW, Leica)(Willig et al., 2007) or pulsed excitation 
STED (TCS STED, Leica)(Hell and Wichmann, 1994) using depletion broadband infrared 
Ti:Sapphire laser (725-850nm, Spectra-Physics, MaiTai) and 100x/1.4 NA oil immersion 
objective lens (HCX PL APO STED, Leica). STED microscopy images were acquired and 
analyzed with the LAS-AF software (Leica). Pulsed-STED microscopy gives a better 
resolution than CW-STED microscopy with our setting on fixed cells. All images of fixed 
cells were processed by pulsed-STED microscopy using Chromeo494 and Atto647 as 
fluoroprobe except for GM1 labelling using an Alexa488 only compatible with the CW-STED 
microscope setting. 
 
Cell preparation and labelling of specific proteins for optical microscopy. 
Equilibrated PBMC or purified CD4 T-cells were loaded (105cells/100l) on poly-L-lysine-
coated round coverslips (14mm-diameter, Marienfeld) in 24-well polystyrene plates at 37°C 
in a thermo-regulated water bath in a 5% CO2 humidified atmosphere. Cells were pretreated 
3 
with prewarmed drugs when indicated: CytD (20M, Sigma), Col (100M, Sigma), COase (1 
u/ml; Sigma) for 30 min and SMase (0.1 u/ml; Sigma) for 5 min at 37°C. 2 nM glycosylated 
IL-7 was added for cell activation. All kinetic studies were performed in a water bath at 37°C 
for precise temperature control. Two protocols were used to prepare cells for microscopy and 
either ensure accurate assay of IL-7 activation products or preserve cell supramolecular 
structure. The first protocol was used to measure the phosphorylation kinetics of STAT5 
where IL-7 action was stopped by 200 l of ice-cold acidic buffer (100 mM glycin-HCl, pH 
2.5), then two washes in 1 ml of ice-cold PBS and fixed in 1.5% PFA/PBS for 5 min at 4°C 
then 15 min at 23°C. The second protocol was used to preserve receptor assemblies and 
microdomains and cytoskeleton organization by stopping IL-7 activation with 1.5% PFA/PBS 
for 15 min at 37°C. 
For membrane microdomain labelling, cells were washed twice by PBS, rehydrated 15min in 
PBS/FBS 5% then labelled 15 min with cholera toxin B (0.5g/ml CtxB-AF488 or CtxB-
AF633, Invitrogen) 15min in PBS/FBS 5%.  
For internal labelling cells were permeabilized by adding 300 l of ice-cold 90% 
methanol/water for 20 min on ice for intracellular labelling. Thus, slides were washed twice 
after methanol treatment in PBS and rehydrated for 15 min in PBS supplemented with 5% 
FBS at room temperature. Slides were labelled with primary antibodies (8g/ml) in PBS/FBS 
buffer for 30 min, washed in PBS/FBS buffer then stained with secondary antibodies 
(0.8g/ml) for 15 min. Slides were washed in PBS/FBS buffer and rinsed in PBS then 
mounted in fresh Mowiol (4-88, Sigma) mounting medium supplemented with antifading 
Dabco (30mg/ml Sigma) for STED microscopy and Vectashield/DAPI (Vector Laboratories) 
for confocal microscopy. The primary antibodies used consisted of rabbit anti-actin (sc1616-r, 
Santa Cruz Biotechnologies, SCB), mouse anti-tubulin (sc5286, SCB), rabbit anti-STAT5a 
(sc1081, SCB), rabbit anti-pSTAT5 (pY694, 9359, Cell Signalling), mouse anti-CD4 
4 
(555343, BD-Pharmingen), mouse anti-CD127 (mAb306, R&D Systems), rat anti-c (TugH4, 
55896, BD-Pharmingen). The secondary antibodies used for pulsed STED microscopy 
consisted of anti-mouse IgG-Chromeo494, anti-rabbit IgG-Chromeo494 and anti-rabbit IgG-
Atto647 (Active Motif). Anti-mouse IgG-AlexaFluor488 (AF488, Invitrogen) and anti-rabbit 
IgG- AF488 (Invitrogen) were used for CW-STED and confocal microscopy. Anti-mouse 
IgG-AlexaFluor633 (AF633, Invitrogen) was used for confocal microscopy.  
 
Protein assays by flow cytometry.  
Cells were cultured in 96-well polystyrene surface-treated plates. Cells were treated treated 
and activated as described above for preparation for microscopy. Non-permeabilized cells 
were surface labelled with CtxB-AF488 (Invitrogen), anti-CD3-V500 (560770, BD-
Bioscience) and anti-CD4-ECD (6604727, Beckman-Coulter). For internal labelling, cells 
were fixed in PFA 1.5% 15 min then permeabilized 20 min in ice-cold 90% methanol/water. 
Cells were washed in PBS and rehydrated in PBS/FBS then surface-labelled with the same 
anti-CD3-V500 and anti-CD4-ECD as above, and labelled inside the cytoplasm with anti-
pSTAT5-AF647 (pY694, 612599, BD-Bioscience). pSTAT5 and GM1 were assayed on 
CD4+ CD3+ human T lymphocytes using a Cyan LX™ cytometer controlled by Summit v4.1 
software (Dako). The results were analyzed with FlowJo v8.3.3 software (Three Star). 
The doses-effects of separated and combined raft inhibitors (COase 0.01-4 u/ml; SMase 0.01-
1 u/ml), and cytoskeleton inhibitors (CytD 0.01-20M; Col 0.01-20M) on STAT5 
phosphorylation were then assayed by flow cytometry as described above. 
We assayed kinetics of IL-7-induced actin and tubulin polymerization by cytometry. 
Activation performed in 96-well plate was stopped by centrifugation (350 g) 1 min at 4°C. 
Cells were washed in cold PBS centrifugated then permeabilized by 0.5% Triton X-100 
(30l) 10 min on ice. We added 250 l of 1.7% PFA (1.5% final) and centrifuged 5 min. 
5 
Cells were washed in cold PBS then incubated 30 min in PBS, 5% FBS at 4°C with anti-actin-
AF647 (sc1616,SCB) and anti-tubulin-AF488 (sc5286,SCB). Cells were washed in cold PBS. 
Receptor chain diffusion rate analysis by fluorescence cross-correlated spectroscopy. 
Fluorescence auto- and cross-correlated spectroscopy (FCS/FCCS) data were acquired on 
living cells using an inverted laser scanning confocal microscope (LSM510, Zeiss) with a 
water-immersion plan-apochromatic 40x/1.2 NA objective lens (Zeiss), combined with a 
ConfoCor2 FCS system (Zeiss). The coverslip temperature in glass-bottom cell culture dish 
(Matek) was controlled at the microscope focus using a Peltier-thermostat monitoring the dish 
holder and the objective ring temperature. The temperature was controlled with a 
thermocouple immerged in the dish once a session. We used for the different acquisitions an 
argon laser beam at 488 nm and a red helium/neon laser beam at 633 nm. Laser powers were 
controlled at the objective focus. FCS and image data were acquired with the LSM software 
(Zeiss). Fluorescence light was split into two detection channels with the following 
excitation/emission wavelengths: AlexaFluor488 [Ar: 488nm/550-600nm] and AlexaFluor633 
[He/Ne: 633 nm/BP680nm]. x-y-z pinhole positions were carefully set to the maximal signal 
from x, y and z-scans to align emission volume center in both channels. The confocal volumes 
of emission with the ConfoCor system were calibrated using a freshly filtered solution of 
rhodamine-6G (Rh6G, Sigma) in water for pinhole size values of 30 to 350 m considering its 
diffusion rate at 25ºC Deff=286m2/s (Bacia and Schwille, 2007b). Fluorescence intensity 
fluctuations associated with Rh6G diffusion were acquired 100 times for 60 sec, the duration 
necessary to average diffusion time with accuracy affected by triplet state relaxation for small 
and fast diffusing molecules. The overlap of the two emission volumes was then tuned with 
the pinhole size values and the collimator setting to find the same diffusion time of Rh6G 
molecules in water in both channels. Settings were then optimized with free streptavidin-
AlexaFluor488 (SAF488) and streptavidin-AlexaFluor633 (SAF633). The observation 
6 
volume of the LSM and the ConfoCor were aligned by bleaching spots with the ConfoCor in 
a dried layer of Rh6G on a 0.16mm-glass slide from crosshair positions in LSM images. 
Pinhole setting, volume overlap and Confocor/LSM alignment were processed before every 
measurement session when laser power and temperature were at the equilibrium. Spot-
variation was monitored by the depth of field spatially filtered through a 30-300m pinhole 
(He and Marguet, 2011; Lenne et al., 2006; Pillet et al., 2010; Rose et al., 2010). 
Rhodamine-6G (Rh6G, Sigma-Aldrich), anti-IL-7R-AF488 (mAb-AF488, R&D Systems), 
streptavidin-Alexa488 (SAF488; Invitrogen), streptavidin-Alexa633 (SAF633), IL-7R/anti-
IL-7R-AF488, c/anti-c-biotin/SAF633 diffusion times were analyzed by autocorrelation of 
their fluorescence fluctuation intensities.  
CD4 T lymphocytes were purified from PBMC, equilibrated 2 h in RPMI/10% FBS at 37°C 
then loaded on poly-lysine coated coverslip in a glass bottom dish and stored 15 min at 37°C. 
When indicated cells were pretreated at 37°C with either raft inhibitors (COase: 25 min, 0.01-
10 u/ml; SMase: 5min, 0.01-10 u/ml) or cytoskeleton inhibitors (CytD: 30 min, 0.01-100M; 
Col: 30 min 0.01-100M) and observed before and after addition of 2nM IL-7. Practically a 
single cell was selected, then IL-7 was added, the confocal volume is centred at the membrane 
level, at the top of the cell at the opposite of the glass. The diffusion was observed during 
activation: each set of FCS and FCCS measurements were taken from 5 to 10 points at the cell 
surface, for 30 sec each, at 6 pinhole size values each, corresponding to 15 to 30 min of total 
acquisition per cell. Tolerance to membrane motion in Z is given by the long shape in Z of the 
confocal volume (structure factor about 5). 15 to 30 min after IL-7 addition the dish was 
discarded to reduce internalisation and aggregation impact on measurements. IL-7-biotin (IL-
7b, R&D Systems) was followed from the IL-7b·SAF488 complex using a molar ratio 1/4 
respectively, to favor the binding of one IL-7b per streptavidin tetramer labelled with AF633.  
7 
Autocorrelation (ACF) and crosscorrelation (CCF) functions G(τ) were built from FCS and 
FCCS raw data respectively and archived with the LSM software (Zeiss). ACF and CCF were 
fitted using different models depending on the number of molecular species carrying the same 
fluorophore labels (from one to three diffusing components) and the location of the focus in 
solution (3D) or on (2D) or out (3D) of the cell membrane according to Schwille and 
colleagues (Bacia et al., 2006; Bacia and Schwille, 2007a, b). 
The one-, two- or three-component models were used in 3D-diffusion in solution or in 
cytoplasm as follows:  
G() =  1/N [1- Ftriplet + F1e-/triplet] i [ (Fi [1+(/i)]-1 [1+(/i)/ s2]-1/2 ]  (Eq.1)  
where N is the number of fluorescent molecules in the effective detection volume element 
defined by Veff= s 3/203, and s is the structural parameter representing its shape from the 
ratio between its axial and lateral radius s = z0/w0 , i is the number of components, Ftriplet and 
triplet are the fraction and relaxation time of particles with their fluorophore in triplet state, Fi 
and τi are the fraction and diffusion time of fluorescent component i. 
Anomalous diffusions of each molecules i was also tested (anomaly parameter i) :  
G() =  1/N [1- Ftriplet + F1e-/triplet] i [Fi [1+(/i)i]-1/2[1+(/i)i/ s2]-1/2 ]  (Eq.2) 
Numbers of particles were evaluated from correlation function: at  =0, G() = 1/N by 
suppressing the triplet relaxation effect. 
Autocorrelation functions were plotted for several increasing confocal emission volumes. The 
diffusion plots were drawn from diffusion times, D, versus squared waists, 02 : 
D = 0 + 02/4Deff  (Eq.3)    where Deff is the effective lateral diffusion rate. 
The confinement time, 0, was extrapolated by linear regression at the y-ordinate for 02 =0 
(Lenne et al., 2006; Marguet et al., 2006; Wawrezinieck et al., 2005).  
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The calibration of the confocal volume emission was processed with rhodamine-6G (Rh6G, 
Sigma) in water for pinhole size values from 30 to 350m. The fluctuations of fluorescence 
intensities associated with the diffusion of Rh6G were acquired 100 times for 60s, duration 
necessary to average the diffusion time with accuracy affected by triplet state relaxation. ACF 
were normalized using Eq.4. 
Normalized G(D) = N ( G(D) – 1)   (Eq.4) 
These ACF were fitted using Eq.1 considering a single component. Diffusion times (D ) were 
extracted from these fitted ACF and plotted versus 02 calculated from the Eq.3. The mean 
diffusion time of Rh6G was 61s corresponding to 02=70·103nm2. The structure factor s was 
approximated to 5.0 from best fits for 02 in the range 50·103 - 150·103 nm2. Below 50·103 
and beyond 150·103 nm2, s deviation indicated that the volume shape was clearly affected and 
restricted the exploration field with our commercial system. The weakness of the apparatus is 
the standard errors on the confocal volume measurements by varying the pinhole in 
comparison with custom-made apparatus (Lenne et al., 2006). 
A 2D-diffusion model was used to fit particle diffusion at the membrane surface: 
G() =  1/N [1- Ftriplet + F1e-/triplet] i [ (Fi [1+(/i)]-1]  (Eq.6)  
Models mixing 3D and 2D-diffusing particles were used to fit diffusion of labelled complex 
IL-7R·mAb-AF488 and c·mAbb·SAF633. We isolated signals of free mAb-AF488 or 
SAF633 by adding a term for free diffusion. 
G() =1/N[1- Ftriplet + F1e-/triplet][ (Fi [1+(/1)]-1 [1+(/1)/ s2]-1/2 ] [ (F2 [1+(/2)]-1] (eq.7) 
where F1 and 1 refer to the 3D-diffusing particle and F2 and 2 refer to the 2D-diffusing 
particles. 
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When indicated two components were considered to split fast and slow 2D-diffusing particles: 
raft-embedded IL-7R, single chain and complex. Anomal diffusion model (Eq.2) improved 
fits for single component models but not significantly for multiple-component models (Eq.7). 
The cross-correlation function between IL-7R·mAb-AF488 and c·mAbb·SAF633 or IL-
7R·mAb-AF488 and IL-7b·SAF633 were fitted using the following 3D and 2D-difusion 
models respectively : 
Gij()=1/Nij[1-Ftriplet,i+Fie-/triplet,i][1-Ftriplet,j+Fje-/triplet,j][Fij[1+(/ij)]-1[1+(/ij)/s2]-1/2]    (Eq.8) 
Gij()=1/Nij[1-Ftriplet,i+Fie-/triplet,i][1-Ftriplet,j+Fje-/triplet,j][Fij[1+(/ij)]-1]        (Eq.9) 
where ij is the diffusion time of the complex. 
AF488/AF633 fluorescence cross-talk was corrected according to individual spectra in both 
channels (Bacia and Schwille, 2007b). Among our major concerns were receptor aggregation 
induced by antibodies or streptavidin, and receptor internalization. Diffusion plots (Eq.3) give 
control of receptor chain aggregation slowing down their diffusion with increasing time: plot 
is curving up when acquisition starts from small to large 02 as observed for diffusion of IL-
7RmAb-A488 beyond 20-30 minutes of acquisition time. Controls were done by target 
saturation with either free unlabelled streptavidin, biotin (Sigma) or mouse IgG added in 
culture media. Usual conditions applied to lower receptor internalization were unfavourable: 
decrease of temperature affected membrane fluidity and cytoskeleton adhesion, and 
deoxyglucose and Na-azide affected receptor compartmentalization. The linearity of the 
diffusion plot (eq.3) was used to reject acquisitions affected by internalization events and 
antibody-induced aggregation.  
 
Western blot analysis. Immunoprecipitations were performed from centrifuged cell lysates in 
Triton X-100 buffer using indicated primary antibodies and immobilized protein G on 
Sepharose-4G (GE-Healthcare) as described previously (Pillet et al., 2010; Rose et al., 2010). 
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Samples were loaded on 1D SDS-PAGE (7% acrylamid-bis and transferred onto a Hybond-
ECL nitrocellulose membrane (GE-Healthcare) overnight at 4°C. Membranes were saturated 
with 2.5% BSA (Sigma) in TBS 0.1% Tween-20, incubated with primary antibodies and 
washed in TBS 0.1% Tween-20 buffer before being incubated with HRP-coupled anti-mouse 
(Jackson), anti-rat (Amersham), anti-rabbit (Jackson)  or anti-goat (Jackson) secondary 
antibodies. Proteins were then revealed by Western lightning plus-ECL detection reagents 
(Perkin-Elmer). The following primary antibodies were used: anti-Jak1 (pAb#sc-295, SCB), 
anti-Jak3 (pAb#sc-513, SCB),  anti-STAT5 (pAb#sc-835, SCB), anti-actin (pAb#sc-1616, 
SCB), anti--tubulin (mAb#sc-5286, SCB), anti-pJak1 (Jak1:pY1034/1035 Ab#44-422G, 
Biosource), anti-pJak3 (Jak3:pY980/pY981, Cell Signalling) and anti-pSTAT5 (pY694, 
Ab#14H2, Cell Signalling), anti-UKHC (pAb#sc-13356, SCB), anti-dynein (pAb#sc-13524, 
SCB). 
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3- SUPPLEMENTAL FIGURES 
 
Supplemental Figure S1: Membrane microdomain formation induced by IL-7 at the 
CD4+ T-cell surface resolved by STED microscopy. These images corresponding to Fig.1a, 
b and c respectively, are shown here at full resolution. GM1 was labelled at the surface of 
purified CD4 T cells with the cholera toxin B coupled to AlexaFluor488. Cells were 
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pretreated 25min with cholesterol oxidase (COase, 1u/ml) then 5 min with sphingomyelinase 
(SMase, 0.1/ml) (c), untreated (a) or activated 15 min with IL-7 2nM (b) at 37°C before 
labelling and PFA-fixation. 
 
Supplemental Figure S2: GM1 assay at the surface of CD4 T lymphocytes by flow 
cytometry. GM1 was labelled at the surface of purified CD4 T cells with the cholera toxin B 
coupled to AlexaFluor 488. Cells were pretreated 25min with cholesterol oxidase (COase, 
1u/ml) then 5 min with sphingomyelinase (SMase, 0.1/ml) (green line), untreated (NS, blue 
line) or activated 15 min with IL-7 2nM (red line) at 37°C before labelling and PFA-fixation. 
IL-7 activation does not affect significantly the amount of cholera toxin targetting GM1 at the 
surface of cells in the first 15 min. 
 
Supplemental Figure S3: IL-7 induces cytoskeleton structuring as observed  
by STED microscopy. Images corresponding to Fig.3a, b and h are shown here at full 
resolution. Actin is colored in red (rabbit anti-actin/anti-rabbit pAb-atto647) and tubulin in green 
(mouse anti-tubulin and anti-mouse pAb-chromeo494). Microfilament and microtubule organization 
was compared by pulsed-STED microscopy before (a), 5 min (b) and 45 min (c, only the green 
channel is shown to display the complex microtubule network) after IL-7 activation of human primary 
CD4 T-cells.  
 
Supplemental Figure S4: FCCS analysis of the cytoskeleton inhibitor effects on the IL-
7R chain diffusion. Normalized autocorrelation functions (ACF) G() were plotted from 5 to 
10 averaged acquisitions versus diffusion times D (log scale in seconds) in figure panel E for 
Rh6G (a), SAF633 (b), mAb-AF488 (c) in colorless completed RPMI media fitted as 3D-
diffusion particles with eq.1. ACF of c·mAbb·SAF633 (d), IL-7R·mAb-AF488 (e) are 
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plotted as mixed 2D/3D-diffusion particles at the surface of CD4 T cells analyzed at 02 
=70•103nm2 and fitted with eq.4. Normalized crosscorrelation functions (CCF) were also 
plotted from 10 averaged acquisitions for IL-7R·mAb-AF488·c·mAbb·SAF633 (f) and IL-
7R/mAb-AF488·c·IL-7b·SAF633 (g) considered as 2D-diffusion particles at the surface of 
CD4 T cells. Residuals from fitting with different mathematical diffusion models are given 
for example in figure panels A-C for IL-7R/mAb-AF488 after ACF fitting with models 
accounting for one 2D-component (A, eq.3), one 2D and one 3D (B, eq.4), two 2D and one 
3D (C, Eq.4). Residuals are also given in figure panel D for IL-7R·mAb-AF488·c·IL-
7b·SAF633 after CCF fitting with models accounting for one 2D-component (D, Eq.8). 
Dashed line indicates half height crosscorrelation function inflexion points of single 
component diffusion. Six ACF are plotted at increasing 02 values for IL-7R·mAb-AF488 
(blue in panel F) and six CCF for IL-7R·mAb-AF488·c·IL-7b·SAF633 (red in panel F). 
Corresponding curves e and g plotted in the panel E acquired at 02 =70•103nm2 are in bold 
and arrowed. Corresponding D values extracted from their fitting were used to build diffusion 
plots (eq.2) as shown in Fig.4a.  
In panel G, 7 CCF are plotted for IL-7R·mAb-AF488·c·IL-7b·SAF633 acquired with 02 
=70•103nm2 at 6 concentrations of CytD (in black: 1,2,5,10,20,100M) and at 0M (g in red). 
The ACF of IL-7R·mAb-AF488 at 0M is plotted for reference. D values are extracted 
from each CCF fitting with models accounting for one 2D-component (Eq.8). The Fig.4a 
plots the D values obtained for the 6 concentrations of CytD acquired at 6 02 values each. 
CytD concentration decreases activated receptor D values: receptor diffusion is released with 
a plateau from 20M. 
In panel H, 7 CCF are plotted for IL-7R·mAb-AF488·c·IL-7b·SA633 acquired with 02 
=70•103nm2 at 6 concentrations of Col (in black: 1,2,5,10,20,100M) and at 0M (g in red). 
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Col concentration does not affect significantly the receptor diffusion. 
In panel I, 10 CCF are plotted for IL-7R·mAb-AF488·c·IL-7b·SA633 acquired with 02 
=70•103nm2 at 3 concentrations of COase, 3 concentrations of SMase and 3 concentrations of 
COase +SMase (in black: 0.1,1,5u/ml) and without inhibitor (g in red). COase +SMase 
concentrations although more efficient than single ones, are weakly affecting the receptor 
diffusion. 
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Fig.S1: Membrane microdomain formation induced by IL-7 
at the CD4+ T-cell surface as labelled by CtxB-AF488 
targetting GM1 and resolved by STED microscopy. Images 
corresponding to Fig.1a, b and c respectively are shown here at 
full resolution.
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Fig.S3: IL-7 induces cytoskeleton structuring as observed
by STED microscopy. Images corresponding to Fig.3a, b and h are shown 
at full resolution. Actin is colored in red and tubulin in green.
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